Last 12 months
Inside the activity.
4 purchase rows · 41 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 12 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2021 Filed Jun 22, 2021 19:51 UTC |
Meynadier MarieDirector
|
GrantCommon Stock | 20,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006957 · edgar.xml · nonDerivative · entry 2 Meynadier Marie · CIK 0001868954 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,672 F2 · security: On June 17, 2021, issuer also granted to the reporting person 20,467 restricted stock units which vest in three equal installments on each of June 17, 2022, June 17, 2023, and June 17, 2024. F3 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F2 · shares: On June 17, 2021, issuer also granted to the reporting person 20,467 restricted stock units which vest in three equal installments on each of June 17, 2022, June 17, 2023, and June 17, 2024. F2 · balance_after: On June 17, 2021, issuer also granted to the reporting person 20,467 restricted stock units which vest in three equal installments on each of June 17, 2022, June 17, 2023, and June 17, 2024. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 19:51 UTC |
Meynadier MarieDirector
|
GrantCommon Stock | 10,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006957 · edgar.xml · nonDerivative · entry 1 Meynadier Marie · CIK 0001868954 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,205 F1 · security: On June 17, 2021, issuer granted to the reporting person 10,205 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F3 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F1 · shares: On June 17, 2021, issuer granted to the reporting person 10,205 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 17, 2021, issuer granted to the reporting person 10,205 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 16, 2021 21:39 UTC |
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
|
Exercise / conversionWarrants to Purchase Common Stock · Derivative | 400,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001567619-21-012222 · doc1.xml · derivative · entry 3 L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization Segal Paul · CIK 0001427470 · 10% owner · Director by deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,346,032 Underlying: Common Stock · 400,000 shares Expires 2023-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. Read SEC document |
| June 16, 2021 Filed Jun 16, 2021 21:39 UTC |
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
|
Tax withholdingCommon Stock | 93,747 | $14.93 | $1,399,642.71 |
DisclosureSEC source: 0001567619-21-012222 · doc1.xml · nonDerivative · entry 2 L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization Segal Paul · CIK 0001427470 · 10% owner · Director by deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,242,761 F3 · shares: Represents a "cashless exercise" of outstanding warrants. The reporting person received 306,253 shares of Common Stock on cashless exercise of warrants to purchase 400,000 shares of Common Stock. The Company withheld 93,747 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on June 15, 2021 of $14.93, pursuant to the terms of the warrant. F1 · ownership.direct: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. Read SEC document |
| June 16, 2021 Filed Jun 16, 2021 21:39 UTC |
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
|
Exercise / conversionCommon Stock | 400,000 | $3.50 | $1,400,000.00 |
DisclosureSEC source: 0001567619-21-012222 · doc1.xml · nonDerivative · entry 1 L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization Segal Paul · CIK 0001427470 · 10% owner · Director by deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,336,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act. F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 18:15 UTC |
Blackford Quentin S.Director
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006868 · edgar.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524,151 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 14:16 UTC |
Mowry David HDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006871 · edgar.xml · nonDerivative · entry 1 Mowry David H · CIK 0001414301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,051 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 14:15 UTC |
MCGINNIS KAREN KDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006870 · edgar.xml · nonDerivative · entry 1 MCGINNIS KAREN K · CIK 0001188264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,660 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 14:16 UTC |
WOODS WARD W JRDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006873 · edgar.xml · nonDerivative · entry 1 WOODS WARD W JR · CIK 0001196931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,959 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 18:14 UTC |
TULLIS JAMES L LDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006866 · edgar.xml · nonDerivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,090 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 14:16 UTC |
Rydin Jeffrey PDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006872 · edgar.xml · nonDerivative · entry 1 Rydin Jeffrey P · CIK 0001345767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,109 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 18:17 UTC |
Sponsel DavidEVP, Sales
|
SaleCommon Stock | 10,000 | $14.78 | $147,800.00 |
DisclosureSEC source: 0001179110-21-006875 · edgar.xml · nonDerivative · entry 1 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 554,317 Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 22:29 UTC |
Pelizzon David RDirector · 10% owner
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025076 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,058 F1 · shares: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. F1 · price: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 18:17 UTC |
Williams Donald AllenDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006874 · edgar.xml · nonDerivative · entry 1 Williams Donald Allen · CIK 0001620013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,728 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 18:15 UTC |
Hochberg JasonDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006869 · edgar.xml · nonDerivative · entry 1 Hochberg Jason · CIK 0001392348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,375 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 18:14 UTC |
Bakst EvanDirector
|
GrantCommon Stock | 10,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006867 · edgar.xml · nonDerivative · entry 1 Bakst Evan · CIK 0001733939 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,361 F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:41 UTC |
Snider BrianEVP, Strat. Mktg. & Prod. Dev.
|
Tax withholdingCommon Stock | 21,982 | $14.81 | $325,553.42 |
DisclosureSEC source: 0001179110-21-005571 · edgar.xml · nonDerivative · entry 1 Snider Brian · CIK 0001702383 · EVP, Strat. Mktg. & Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619,190 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F2 · balance_after: Includes 1,510 shares acquired under the issuer's employee stock purchase plan on May 14, 2021. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:40 UTC |
Howell Kelli MariEVP, Clinical Strategies
|
Tax withholdingCommon Stock | 17,525 | $14.81 | $259,545.25 |
DisclosureSEC source: 0001179110-21-005569 · edgar.xml · nonDerivative · entry 1 Howell Kelli Mari · CIK 0001734485 · EVP, Clinical Strategies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,449 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F2 · balance_after: Includes 2,507 shares acquired under the issuer's employee stock purchase plan on May 14, 2021. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:29 UTC |
Sponsel DavidEVP, Sales
|
Tax withholdingCommon Stock | 34,087 | $14.81 | $504,828.47 |
DisclosureSEC source: 0001179110-21-005568 · edgar.xml · nonDerivative · entry 1 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,317 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F2 · balance_after: Includes 220 shares acquired under the issuer's employee stock purchase plan on May 14, 2021. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:28 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
Tax withholdingCommon Stock | 28,271 | $14.81 | $418,693.51 |
DisclosureSEC source: 0001179110-21-005567 · edgar.xml · nonDerivative · entry 1 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,869 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:56 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 1,000 | $14.50 | $14,500.00 |
DisclosureSEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 4 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000 F4 · ownership.nature: These shares are held by the Pritzker Military Foundation. As the sole member of the Pritzker Military Foundation, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:56 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 1,000 | $14.50 | $14,500.00 |
DisclosureSEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 3 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000 F3 · ownership.nature: These shares are held by the Tawani Foundation. As the sole member of the Tawani Foundation, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:56 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 1,000 | $14.50 | $14,500.00 |
DisclosureSEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 2 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000 F2 · ownership.nature: These shares are held by the Pritzker Military Museum and Library ("PMML"). As the sole member of PMML, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:56 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 4,000 | $14.38 | $57,520.00 |
DisclosureSEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 1 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,200 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.37 to $14.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:25 UTC |
Pelizzon David RDirector · 10% owner
|
PurchaseCommon Stock | 120,000 | $15.25 | $1,830,000.00 |
DisclosureSEC source: 0000899243-21-019280 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,837 Read SEC document |
| May 03, 2021 Filed May 5, 2021 00:10 UTC |
Sponsel DavidEVP, Sales
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,813 | $0.00 Strike: $3.17 | $0.00 |
DisclosureSEC source: 0001179110-21-004879 · edgar.xml · derivative · entry 5 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 Underlying: Common Stock · 12,813 shares Expires 2028-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vest 25% on November 2, 2019 and thereafter in 36 equal monthly installments. Read SEC document |
| May 03, 2021 Filed May 5, 2021 00:10 UTC |
Sponsel DavidEVP, Sales
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,187 | $0.00 Strike: $3.86 | $0.00 |
DisclosureSEC source: 0001179110-21-004879 · edgar.xml · derivative · entry 4 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,813 Underlying: Common Stock · 17,187 shares Expires 2028-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vest 25% on May 29, 2019 and thereafter in 36 equal monthly installments. Read SEC document |
| May 03, 2021 Filed May 5, 2021 00:10 UTC |
Sponsel DavidEVP, Sales
|
SaleCommon Stock | 30,000 | $15.97 | $479,100.00 |
DisclosureSEC source: 0001179110-21-004879 · edgar.xml · nonDerivative · entry 3 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,184 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2021 Filed May 5, 2021 00:10 UTC |
Sponsel DavidEVP, Sales
|
Exercise / conversionCommon Stock | 12,813 | $3.17 | $40,617.21 |
DisclosureSEC source: 0001179110-21-004879 · edgar.xml · nonDerivative · entry 2 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 5, 2021 00:10 UTC |
Sponsel DavidEVP, Sales
|
Exercise / conversionCommon Stock | 17,187 | $3.86 | $66,341.82 |
DisclosureSEC source: 0001179110-21-004879 · edgar.xml · nonDerivative · entry 1 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 615,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed May 3, 2021 12:42 UTC |
Miles PatrickDirector · CEO
|
Tax withholdingCommon Stock | 146,074 | $16.33 | $2,385,388.42 |
DisclosureSEC source: 0001179110-21-004762 · edgar.xml · nonDerivative · entry 1 Miles Patrick · CIK 0001289409 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,958,775 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| April 29, 2021 Filed May 3, 2021 16:44 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
Tax withholdingCommon Stock | 22,381 | $16.33 | $365,481.73 |
DisclosureSEC source: 0001179110-21-004765 · edgar.xml · nonDerivative · entry 1 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080,140 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| April 29, 2021 Filed May 3, 2021 16:43 UTC |
Snider BrianEVP, Strat. Mktg. & Prod. Dev.
|
Tax withholdingCommon Stock | 20,080 | $16.33 | $327,906.40 |
DisclosureSEC source: 0001179110-21-004764 · edgar.xml · nonDerivative · entry 1 Snider Brian · CIK 0001702383 · EVP, Strat. Mktg. & Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,662 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| April 29, 2021 Filed May 3, 2021 16:42 UTC |
Howell Kelli MariEVP, Clinical Strategies
|
Tax withholdingCommon Stock | 11,474 | $16.33 | $187,370.42 |
DisclosureSEC source: 0001179110-21-004763 · edgar.xml · nonDerivative · entry 1 Howell Kelli Mari · CIK 0001734485 · EVP, Clinical Strategies 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512,467 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| April 26, 2021 Filed Apr 28, 2021 13:52 UTC |
Sponsel DavidEVP, Sales
|
SaleCommon Stock | 14,572 | $16.63 | $242,332.36 |
DisclosureSEC source: 0001179110-21-004643 · edgar.xml · nonDerivative · entry 1 Sponsel David · CIK 0001772837 · EVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,184 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.42 to $16.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 14:26 UTC |
Koning John ToddChief Financial Officer
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004531 · edgar.xml · nonDerivative · entry 2 Koning John Todd · CIK 0001830843 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 F2 · security: On April 19, 2021, the issuer also granted to the reporting person 40,000 RSUs, which vest in three equal installments on each of February 18, 2022, February 18, 2023, and February 18, 2024. F3 · security: Each RSU represents a contingent right to receive one share of the issuer's common stock. F2 · shares: On April 19, 2021, the issuer also granted to the reporting person 40,000 RSUs, which vest in three equal installments on each of February 18, 2022, February 18, 2023, and February 18, 2024. F2 · balance_after: On April 19, 2021, the issuer also granted to the reporting person 40,000 RSUs, which vest in three equal installments on each of February 18, 2022, February 18, 2023, and February 18, 2024. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 14:26 UTC |
Koning John ToddChief Financial Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004531 · edgar.xml · nonDerivative · entry 1 Koning John Todd · CIK 0001830843 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · security: On April 19, 2021, the issuer granted to the reporting person 150,000 restricted stock units (RSUs), which vest in four equal installments on each of the first four anniversaries of the grant date. F3 · security: Each RSU represents a contingent right to receive one share of the issuer's common stock. F1 · shares: On April 19, 2021, the issuer granted to the reporting person 150,000 restricted stock units (RSUs), which vest in four equal installments on each of the first four anniversaries of the grant date. F1 · balance_after: On April 19, 2021, the issuer granted to the reporting person 150,000 restricted stock units (RSUs), which vest in four equal installments on each of the first four anniversaries of the grant date. Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 20:13 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
Exercise / conversionWarrants (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001179110-21-004374 · edgar.xml · derivative · entry 4 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2022-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 12, 2021 20:13 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
Exercise / conversionCommon Stock | 100,000 | $2.00 | $200,000.00 |
DisclosureSEC source: 0001179110-21-004374 · edgar.xml · nonDerivative · entry 3 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 20:13 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
SaleCommon Stock | 5,840 | $18.00 | $105,120.00 |
DisclosureSEC source: 0001179110-21-004374 · edgar.xml · nonDerivative · entry 2 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,002,521 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 20:13 UTC |
Hunsaker Craig EEVP, People/Culture & GC
|
SaleCommon Stock | 25,000 | $16.23 | $405,750.00 |
DisclosureSEC source: 0001179110-21-004374 · edgar.xml · nonDerivative · entry 1 Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,008,361 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.89 to $16.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 25, 2021 Filed Mar 26, 2021 22:38 UTC |
Snider BrianEVP, Strat. Mktg. & Prod. Dev.
|
Tax withholdingCommon Stock | 6,484 | $16.68 | $108,153.12 |
DisclosureSEC source: 0001179110-21-003833 · edgar.xml · nonDerivative · entry 1 Snider Brian · CIK 0001702383 · EVP, Strat. Mktg. & Prod. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,742 F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units. Read SEC document |
| March 11, 2021 Filed Feb 10, 2022 20:36 UTC |
Miles PatrickDirector · CEO
|
GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001030 · edgar.xml · nonDerivative · entry 1 Miles Patrick · CIK 0001289409 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,026,394 Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:57 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 1,000 | $16.31 | $16,310.00 |
DisclosureSEC source: 0000899243-21-011377 · doc4.xml · nonDerivative · entry 3 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,200 Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:57 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 1,000 | $16.42 | $16,420.00 |
DisclosureSEC source: 0000899243-21-011377 · doc4.xml · nonDerivative · entry 2 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 Read SEC document |
| March 10, 2021 Filed Mar 12, 2021 23:57 UTC |
Pritzker Jennifer N.10% owner
|
PurchaseCommon Stock | 1,000 | $16.40 | $16,400.00 |
DisclosureSEC source: 0000899243-21-011377 · doc4.xml · nonDerivative · entry 1 Pritzker Jennifer N. · CIK 0001850165 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,200 Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 21:14 UTC |
Black Jeffrey G.EVP & CFO
|
SaleCommon Stock | 7,000 | $16.69 | $116,830.00 |
DisclosureSEC source: 0001179110-21-003246 · edgar.xml · nonDerivative · entry 1 Black Jeffrey G. · CIK 0001449439 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620,770 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019, as amended November 27, 2020, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock unit awards. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.12 to $17.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 09, 2021 Filed Mar 12, 2021 01:20 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 22,500 | $16.24 | $365,400.00 |
DisclosureSEC source: 0001179110-21-003288 · edgar.xml · nonDerivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Tullis Growth Fund, L.P. Disclosed balance after: 545,747 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:48 UTC |
Pelizzon David RDirector · 10% owner
|
PurchaseCommon Stock | 695 | $15.93 | $11,071.35 |
DisclosureSEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 2 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,837 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:48 UTC |
Pelizzon David RDirector · 10% owner
|
PurchaseCommon Stock | 4,003 | $15.50 | $62,046.50 |
DisclosureSEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 1 Pelizzon David R · CIK 0001719217 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,142 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.